Hemab Therapeutics IPO

Hemab Therapeutics, founded in 2019, specializes in developing treatments for patients with bleeding and thrombotic disorders. Specifically, the company focuses on finding preventive treatments for less-common disorders for which fewer treatments are currently available. The company’s therapies are designed to accumulate, modulate, and make use of endogenous clotting factors in patients to form hemostatic plugs when it matters most.

Register for Details

For more details on financing and valuation for Hemab Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Hemab Therapeutics

Forge green plus iconForge green minus icon

What is Hemab Therapeutics's IPO price?

The IPO price for Hemab Therapeutics will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Hemab Therapeutics?

Hemab Therapeutics is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Hemab Therapeutics shares pre-IPO?

If you own Hemab Therapeutics pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Hemab Therapeutics a publicly traded company?

Hemab Therapeutics is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

When was Hemab Therapeutics founded?

Hemab Therapeutics was founded in 2022.

Who are Hemab Therapeutics's major investors?

Ra Capital Management
Rock Springs Capital
Novo Holdings
The Invus Group
Deep Track Capital
Access Biotechnology
Avoro Ventures
Maj Invest
BioInnovation Institute
Updated on: Apr 15, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.